Prime Capital Investment Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 15,057 shares of DNA stock, worth $115,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,057
Previous 20,507
26.58%
Holding current value
$115,938
Previous $23,000
82.61%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DNA
# of Institutions
346Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.07 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.04 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$538 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$323 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.92B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...